You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ISOSORBIDE MONONITRATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for isosorbide mononitrate and what is the scope of patent protection?

Isosorbide mononitrate is the generic ingredient in four branded drugs marketed by Schering Plough, Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Aurobindo Pharma, Chartwell Molecular, Dexcel Ltd, Hikma Intl Pharms, Ivax Sub Teva Pharms, Riconpharma Llc, Shandong, Skyepharma Ag, Strides Pharma, Torrent Pharms, Zydus Hlthcare, Zydus Pharms, Promius Pharma, Ani Pharms, Hikma Pharms, and Omnivium Pharms, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for isosorbide mononitrate. Twenty-four suppliers are listed for this compound.

Summary for ISOSORBIDE MONONITRATE
Drug Prices for ISOSORBIDE MONONITRATE

See drug prices for ISOSORBIDE MONONITRATE

Drug Sales Revenue Trends for ISOSORBIDE MONONITRATE

See drug sales revenues for ISOSORBIDE MONONITRATE

Recent Clinical Trials for ISOSORBIDE MONONITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Al-Azhar UniversityEarly Phase 1
Cairo UniversityPhase 1
Suez Canal UniversityEarly Phase 1

See all ISOSORBIDE MONONITRATE clinical trials

Pharmacology for ISOSORBIDE MONONITRATE
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Anatomical Therapeutic Chemical (ATC) Classes for ISOSORBIDE MONONITRATE

US Patents and Regulatory Information for ISOSORBIDE MONONITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecular ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075155-001 Oct 30, 1998 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dexcel Ltd ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075522-002 Sep 20, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 090598-003 Aug 11, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Hlthcare ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075395-001 Mar 16, 2000 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075448-003 Aug 7, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 218255-001 Feb 15, 2024 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Omnivium Pharms MONOKET isosorbide mononitrate TABLET;ORAL 020215-001 Jun 30, 1993 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.